Login to Your Account



'Unprecedented' Plaque Clearance

Eisai Lymphoma Drug Reverses Alzheimer's Disease Symptoms

By Anette Breindl
Science Editor

Monday, February 13, 2012
Researchers identified a drug which, in animals, rapidly decreases both plaque area and soluble amyloid beta levels in mouse models of Alzheimer's disease. And it's FDA-approved.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription